Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabre Insurance Group Regulatory News (SBRE)

Share Price Information for Sabre Insurance Group (SBRE)

Share Price is delayed by 15 minutes
Get Live Data
157.60    3.80 (2.47%)
Bid:
157.60
Ask:
158.00
Spread: 0.40 (0.254%)
Market Cap: £385.03m
SBRE Live PriceLast checked at - London Stock Exchange

Intraday Sabre Insurance Group Share Chart

Trading Update

16 Oct 2025 07:00

RNS Number : 5665D
Sabre Insurance Group PLC
16 October 2025
 

 

16 October 2025

Sabre Insurance Group plc

Trading Update

Full-year profit guidance reiterated, Ambition 2030 initiatives on-track

Sabre Insurance Group plc (the "Group" or "Sabre"), one of the UK's leading motor insurance underwriters, today provides an update on trading for the period from 1 July 2025 to 30 September 2025.

Unaudited

Nine months ended

30 September

Year ended

31 December

 

2025

2024

% Change

 2024

Gross written premium - Motor Vehicle

£133.1m

£165.6m

(19.6)%

£209.9m

Gross written premium - Motorcycle

£8.7m

£8.2m

6.1%

£9.7m

Gross written premium - Taxi

£9.9m

£12.7m

(22.0)%

£16.8m

Gross written premium - Total

£151.7m

£186.5m

(18.7)%

£236.4m

Key Highlights

‒ Full-year profit guidance reiterated, expected to be in-line with 2024

‒ Pricing discipline maintained and policies continue to be written at target margins of 18% - 22%

‒ Cautious claims inflation assumptions fully covered, supporting an anticipated strong profit in 2025 and 2026 as well as continued target-level profitability into the medium-term

‒ Gross written premium continues at a healthy level despite broader market pricing remaining subdued

‒ £5 million share buyback programme completed

‒ Continued strong capital generation underpins confidence in the ability to make an attractive capital distribution at year-end

‒ Good progress towards Ambition 2030, and not impacted by the present cyclical market weakness

 

Market trends

‒ Continued signs of claims inflation moderating, now at a mid-single-digit level

‒ The fall in market pricing appears to be stabilising having seen prices fall consistently through the first half of the year

We continue to expect market pricing to increase in late 2025 or early 2026 to avoid significantly undermining 2026/2027 market-level profitability

 

Outlook

‒ In-line with previous guidance, full-year profit is expected to be in-line with 2024, as we execute on our pricing discipline and margin management strategy, with a net insurance margin within our target range

‒ We continue to expect a healthy if slightly reduced premium out-turn for the year as we maintain focus on maximising absolute profit by writing business at appropriate margins

‒ Beyond 2025, we foresee good profitability as we deliver on Ambition 2030

‒ Continued strong capital generation supports the Board's confidence in the ability to provide an attractive capital distribution at year-end

 

Geoff Carter, Chief Executive Officer of Sabre, commented:

"I continue to be pleased with our performance at the Q3 stage of 2025. Our long-term focus on margins over volume means we are confident of delivering a strong full-year result with profits in-line with 2024 with a very robust capital position, despite market-wide motor premium pricing weakness for large parts of 2025.

Because Sabre has focussed on maintaining pricing discipline through 2025, we are also confident of maintaining strong margins and delivering good profitability into 2026 and beyond.

Whilst it is slightly frustrating that the market has underpriced against on-going claims inflation, we had anticipated this, and it is factored into our business model. It is reassuring that we continue to write healthy levels of premium at our target margins during this part of the market cycle.

In recent weeks we have seen some positive momentum in our weekly premium levels and modest growth returning in our core motor book. At this stage this is driven by our own pricing initiatives rather than the anticipated market turn.

Our Ambition 2030 initiatives continue to develop at pace, and we remain confident on delivering on our targets. Combined with our long-term and stress-tested strategy, this means we can continue to deliver good performance at all points of the market cycle - growing and contracting as appropriate in the short-term, whilst delivering meaningful profit growth in the longer term."

 

 

Investor enquiries

01306 747 272

Sabre Insurance Group plc

Geoff Carter / Adam Westwood

Media enquiries

020 7353 4200

Teneo

sabre@teneo.com

James Macey White / Ffion Dash

 

LEI Code: 2138006RXRQ8P8VKGV98

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFFIFWIEISEIS
Date   Source Headline
7th Jul 20257:00 amRNSTransaction in Own Shares
4th Jul 20257:00 amRNSTransaction in Own Shares
3rd Jul 20257:00 amRNSTransaction in Own Shares
2nd Jul 20257:00 amRNSTransaction in Own Shares
1st Jul 20257:00 amRNSTransaction in Own Shares
17th Jun 20254:35 pmRNSDirector/PDMR Shareholding
11th Jun 20251:38 pmRNSDirector/PDMR Shareholding
5th Jun 202511:16 amRNSDirector/PDMR Shareholding
22nd May 202511:38 amRNSResult of AGM
22nd May 20257:00 amRNSTrading Update
13th May 20253:18 pmRNSDirector/PDMR Shareholding
17th Apr 20259:40 amRNSDirector/PDMR Shareholding
11th Apr 20251:26 pmRNSDirector/PDMR Shareholding
10th Apr 20251:09 pmRNSDirector/PDMR Shareholding
8th Apr 20254:31 pmRNSDirector/PDMR Shareholding
8th Apr 20253:54 pmRNSDirector/PDMR Shareholding
8th Apr 20251:53 pmRNSDirector/PDMR Shareholding
4th Apr 20253:20 pmRNSNotice of AGM
27th Mar 20258:37 amRNSDirector/PDMR Shareholding
20th Mar 202511:39 amRNSDirector/PDMR Shareholding
18th Mar 20257:00 amRNSFinal Results
11th Mar 20251:21 pmRNSDirector/PDMR Shareholding
24th Feb 202511:23 amRNSNotice of Results
11th Feb 20253:12 pmRNSDirector/PDMR Shareholding
13th Jan 20252:14 pmRNSDirector/PDMR Shareholding
11th Dec 202411:57 amRNSDirector/PDMR Shareholding
5th Dec 20247:00 amRNSCapital Markets Event
21st Nov 202410:28 amRNSAppointment of Joint Corporate Broker
12th Nov 20241:15 pmRNSDirector/PDMR Shareholding
23rd Oct 20244:13 pmRNSHolding(s) in Company
22nd Oct 20242:43 pmRNSDirector/PDMR Shareholding
22nd Oct 20242:40 pmRNSDirector/PDMR Shareholding
22nd Oct 20247:00 amRNSTrading Update
18th Oct 20243:25 pmRNSHolding(s) in Company
11th Oct 202412:40 pmRNSDirector/PDMR Shareholding
26th Sep 20241:25 pmRNSDirector/PDMR Shareholding
11th Sep 202412:21 pmRNSDirector/PDMR Shareholding
11th Sep 20249:51 amRNSHolding(s) in Company
6th Sep 20242:29 pmRNSHolding(s) in Company
30th Aug 202411:50 amRNSDirector/PDMR Shareholding
22nd Aug 20244:22 pmRNSHolding(s) in Company
14th Aug 20243:33 pmRNSHolding(s) in Company
13th Aug 202412:48 pmRNSDirector/PDMR Shareholding
30th Jul 20247:00 amRNSHalf-year Report 2024
22nd Jul 20247:00 amRNSNotice of Results
11th Jul 202412:25 pmRNSDirector/PDMR Shareholding
3rd Jul 20243:40 pmRNSHolding(s) in Company
19th Jun 202412:28 pmRNSAppointment of Non-executive Director
14th Jun 20249:50 amRNSDirector/PDMR Shareholding
11th Jun 202411:54 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.